Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eisai
Eisai
Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA (perampanel) Pediatric Indications
CP Wire
Mon, 04/2/18 - 03:03 pm
Eisai
FDA
Fycompa
pediatric
seizures
Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA (perampanel) Pediatric Indications
Mon, 04/2/18 - 12:31 am
Fycompa
Eisai
pediatric epilepsy
Eisai partners with Nichi-Iko in generics pact
Biopharma Dive
Sat, 03/31/18 - 10:02 am
Eisai
Nichi-Iko
generics
Doubling down on the Keytruda franchise, Merck pays $300M and promises $5B-plus to partner with Eisai on its budding cancer star
Endpoints
Thu, 03/8/18 - 09:42 am
Merck
Keytruda
Eisai
Lenvima
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
GoinPharma
Wed, 01/17/18 - 10:05 am
Eisai
Merck
Bristol-Myers Squibb
kidney cancer
Keytruda
Lenvima
Opdivo
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Fierce Pharma
Fri, 01/12/18 - 06:39 pm
Merck
Eisai
Keytruda
Lenvima
kidney cancer
Looking for an early success in PhII Alzheimer’s study, Biogen and Eisai just racked up the latest setback
Endpoints
Thu, 12/21/17 - 10:26 am
Biogen
Eisai
clinical trials
Alzheimer's disease
BAN2401
Eisai tracking device keeps tabs on out-and-about dementia patients
Fierce Pharma
Wed, 11/29/17 - 10:04 am
Eisai
dementia
Mamorio
devices
Me-Mamorio
Alzheimer's disease
Eisai shows confidence in Biogen's Alzheimer's drug
Biopharma Dive
Mon, 10/23/17 - 09:49 pm
Eisai
Biogen
Alzheimer's disease
aducanumab
Upstart women’s oncology company in-licenses PhII PARP; Beijing biotech grabs $29M startup round
Endpoints
Fri, 07/7/17 - 10:18 am
oncology
PARP inhibitors
2X Oncology
Eisai
2X-121
Jazz Pharmaceuticals
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Sun, 06/4/17 - 11:51 am
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
Eisai extends CRO partnership for malaria drug discovery
BioPharma Dive
Thu, 06/1/17 - 02:47 pm
Eisai
CRO
drug development
malaria
Arena Turns Page On Belviq - Restructures Deal With Eisai
Seeking Alpha
Thu, 01/5/17 - 09:15 am
Arena Pharmaceuticals
Belviq
Eisai
Eisai latest cancer drugmaker to win UK approval after price cut
Yahoo/Reuters
Thu, 11/3/16 - 09:29 am
Eisai
Halaven
UK
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
Yahoo
Mon, 10/3/16 - 09:56 am
Eisai
Arena Pharmaceuticals
Belviq XR
Eisai launches research division in Massachusetts aimed at Alzheimer’s, I/O and autoimmune diseases
Endpoints
Thu, 09/15/16 - 09:29 am
Eisai
R&D
Massachusetts
Alzheimer's disease
autoimmune disease
Eisai joins hands with Biogen on PhIII Alzheimer’s BACE trial
Fierce Pharma
Wed, 08/10/16 - 10:11 am
Eisai
Biogen
BACE inhibitors
clinical trials
Alzheimer's disease
E2609
Biogen, Eisai’s Alzheimer’s Drug E2609 to Enter Late-Stage Trial
Bloomberg
Tue, 08/9/16 - 10:45 am
Biogen
Eisai
Alzheimer's disease
E2609
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Marketwatch
Tue, 07/19/16 - 09:57 am
Arena Pharmaceuticals
FDA
obesity
Eisai
Belviq XR
Eisai's kidney drug wins expanded indication in the U.S.
BioPharma Dive
Tue, 05/17/16 - 09:35 am
Eisai
advanced renal cell carcinoma
kidney cancer
Lenvima
RCC
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »